Posted by Michael Wonder on 08 May 2024
First patient begins newly approved sickle cell gene therapy
6 May 2024 - On Wednesday, Kendric Cromer, a 12 year old boy from a suburb of Washington, became the first person in the world with sickle cell disease to begin a commercially approved gene therapy that may cure the condition.
For the estimated 20,000 people with sickle cell in the United States who qualify for the treatment, the start of Kendric’s months long medical journey may offer hope. But it also signals the difficulties patients face as they seek a pair of new sickle cell treatments.
